[1]范华平,成小凤,何云,等.反应性充血指数预测非阻塞性急性冠脉综合征患者的中远期预后[J].第三军医大学学报,2018,40(09):836-840.
 FAN Huaping,CHENG Xiaofeng,HE Yun,et al.Reactive hyperemia index predicts mid-long-term prognosis of non-obstructive acute coronary syndrome[J].J Third Mil Med Univ,2018,40(09):836-840.
点击复制

反应性充血指数预测非阻塞性急性冠脉综合征患者的中远期预后(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第09期
页码:
836-840
栏目:
临床医学
出版日期:
2018-05-15

文章信息/Info

Title:
Reactive hyperemia index predicts mid-long-term prognosis of non-obstructive acute coronary syndrome
作者:
范华平成小凤何云刘婷潘文旭晋军
陆军军医大学(第三军医大学)第二附属医院心血管内科
Author(s):
FAN Huaping CHENG Xiaofeng HE Yun LIU Ting PAN Wenxu JIN Jun

Department of Cardiology, Institute of Cardiovascular Diseases, Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037, China

关键词:
非阻塞性急性冠脉综合征反应性充血指数预后
Keywords:
non-obstructive acute coronary syndrome: reactive hyperemia index prognosis
分类号:
R181.32; R540.4; R543.3
文献标志码:
A
摘要:

目的     探讨反应性充血指数(reactive hyperemia index,RHI)与非阻塞性急性冠脉综合征(non-obstructive acute coronary syndrome,NobACS)患者中远期心脏不良事件(cardiac adverse events,AEs)的关系。方法    本研究为前瞻性队列研究,连续收集陆军军医大学第二附属医院2015年10月至2017年7月NobACS住院患者290例,依据RHI是否<1.67分为内皮功能障碍(abnormal endothelial function,AEF)组166例,内皮功能正常(normal endothelial function,NEF)组124例,随访(14.0±4.5)个月,记录AEs,包括全因死亡、缺血性卒中、非致命性心肌梗死和因心血管事件再次住院,通过生存分析比较两组AEs事件的差异。结果    AEF组、NEF组分别失访10例、7例。共有59例AEs事件发生。与NEF组比较,AEF组因心血管事件再次住院率显著升高(P<0.05),全因死亡、缺血性卒中、非致命性心肌梗死2组比较无统计学差异(P>0.05),总AEs事件率显著升高(P<0.01)。多因素Cox比例风险回归模型提示RHI<1.67(校正后HR=2.20,95%CI=1.24~3.92,P<0.01)是AEs事件的独立预测因子。结论    RHI可用于NobACS患者的中远期预后判断,RHI<1.67是NobACS患者预后的独立预测因子。

Abstract:

Objective    To investigate the relationship between reactive hyperemia index (RHI) and midlongterm cardiac adverse events (AEs) in the patients with non-obstructive acute coronary syndrome (NobACS).  Methods    A prospective cohort trial was carried out on 290 consecutive patients with NobACS admitted in our hospital from October 2015 to July 2017. According to their RHI, they were divided into abnormal endothelial function group (AEF, n=166, RHI<1.67) and normal endothelial function group (NEF, n=124, RHI≥1.67). The patients were averagely followed up for 14.0±4.5 months. AEs were defined as all-cause death, ischemic stroke, non-fatal myocardial infarction and re-hospitalization for cardiovascular events. Survival analysis was performed to compare the difference in AC occurrence between the 2 groups.  Results    There were 10 and 7 patients lost respectively in the AEF and NEF groups during the follow-up. AEs occurred in 59 patients. The AEs incidence (P<0.01) and re-hospitalization rate (P<0.05) were significantly higher in the AEF group than the NEF group. But there were no differences in the incidences of all-cause death, ischemic stroke and non-fatal myocardial infarction (P>0.05). Multifactor Cox proportional hazards regression model showed RHI<1.67 (HR=2.20, 95%CI: 1.24~3.92, P<0.01 after adjustment) was an independent prognostic factor for predicting AEs. Conclusion    RHI could be used in prediction of mid-long-outcome of NobACS. RHI<1.67 is an independent prognostic factor for NobACS.

参考文献/References:

[1]AMSTERDAM E A,WENGER N K,BRINDIS R G,et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the american college of cardiology/american heart association task force on practice guidelines[J]. J Am Coll Cardiol, 2014,64(24):e139-e228. DOI: 10.1016/j.jacc.2014.09.017.
[2]NICCOLI G,SCALONE G,CREA F. Acute myocardial infarction with no obstructive coronary atherosclerosis:mechanisms and management[J]. Eur Heart J,2015,36(8):475-481. DOI:10.1093/eurheartj/ehu469.
[3]PASUPATHY S,AIR T,DREYER R, et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries[J]. Circulation,2015,132(19):861-870. DOI:10.1161/CIRCULATIONAHA.114.011201.
[4]BUGIARDINI R,BAIREY MERZ C N. Angina with “normal” coronary arteries:a changing philosophy[J]. JAMA, 2005, 293(4):477-484. DOI:10.1001/jama.293.4.477.
[5]PIZZI C,XHYHERI B,COSTA G M,et al. Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome:A MetaAnalysis[J]. J Am Heart Assoc, 2016, 5(12): e004185. DOI: 10.1161/JAHA.116.004185.
[6]JOHNSTON N,JNELID B,CHRISTERSSON C,et al. Effect of gender on patients with STelevation and nonSTelevation myocardial infarction without obstructive coronary artery disease[J]. Am J Cardiol, 2015,115(12):1661-1666. DOI:10.1016/j.amjcard.2015.03.006.
[7]CREA F,CAMICI P G,BAIREY MERZ C N. Coronary microvascular dysfunction:an update[J]. Eur Heart J, 2014, 35(17):1101-1111. DOI:10.1093/eurheartj/eht513.
[8]SHECHTER M,MATEZKY S,PRASAD M,et al. Endothelial function predicts 1-year adverse clinical outcome in patients hospitalized in the emergency department chest pain unit[J]. Int J Cardiol,2017,240:14-19. DOI:10.1016/j.ijcard.2017.04.101.
[9]VEERASAMY M,BAGNALL A,NEELY D,et al. Endothelial dysfunction and coronary artery disease:a state of the art review[J]. Cardiol Rev,2015,23(3):119-129. DOI:10.1097/CRD.0000000000000047.
[10]MATSUZAWA Y,SUGIYAMA S,SUGAMURA K,et al. Digital assessment of endothelial function and ischemic heart disease in women[J]. J Am Coll Cardiol, 2010, 55(16): 1688-1696. DOI:10.1016/j.jacc.2009.10.073.
[11]SCHOENENBERGER A W,URBANEK N, BERGNER M, et al. Associations of reactive hyperemia index and intravascular ultrasoundassessed coronary plaque morphology in patients with coronary artery disease[J]. Am J Cardiol,2012, 109(12): 1711-1716. DOI:10.1016/j.amjcard.2012.02.011.
[12]RUBINSHTEIN R,KUVIN JT,SOFFLER M, et al. Assessment of endothelial function by noninvasive peripheral arterial tonometry predicts late cardiovascular adverse events[J]. Eur Heart J, 2010, 31(9):1142-1148. DOI:10.1093/eurheartj/ehq010.
[13]AKIYAMA E,SUGIYAMA S,MATSUZAWA Y,et al. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction[J]. J Am Coll Cardiol, 2012, 60(18): 1778-1786. DOI:10.1016/j.jacc.2012.07.036.
[14]LAVI S,BAE J H,RIHAL C S,et al. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques[J]. Heart,2009,95(18):1525-1530. DOI:10.1136/hrt.2009.166017.
[15]HIGASHI Y. Assessment of endothelial function. History, methodological aspects, and clinical perspectives[J]. Int Heart J,2015, 56(2):125-134. DOI:10.1536/ihj.14385.
[16]FLAMMER A J,ANDERSON T,CELERMAJER D S,et al. The assessment of endothelial function: from research into clinical practice[J]. Circulation,2012,126(6):753-767. DOI:10.1161/CIRCULATIONAHA.112.093245.
[17]DAVIGNON J,GANZ P. Role of endothelial dysfunction in atherosclerosis[J]. Circulation, 2004, 109(23 Suppl 1):27-32. DOI: 10.1161/01.CIR.0000131515.03336.f8.
[18]LERMAN A,ZEIHER A M. Endothelial function:cardiac events[J]. Circulation,2005,111(3):363-368. DOI: 10.1161/01.CIR.0000153339.27064.14.
[19]KOMURA N,TSUJITA K,YAMANAGA K,et al. Impaired peripheral endothelial function assessed by digital reactive hyperemia peripheral arterial tonometry and risk of instent restenosis[J]. J Am Heart Assoc, 2016, 5(6):e003202. DOI: 10.1161/JAHA.116.003202.
[20]SARA J D S,PRASAD M,ZHANG M,et al. Highsensitivity Creactive protein is an independent marker of abnormal coronary vasoreactivity in patients with nonobstructive coronary artery disease[J]. Am Heart J,2017,190:1-11. DOI: 10.1016/j.ahj.2017.02.035.
[21]TUTTOLOMONDO A,CASUCCIO A, DELLA C V, et al. Endothelial function and arterial stiffness indexes in subjects with acute ischemic stroke:relationship with TOAST subtype[J]. Atherosclerosis,2017,256:94-99.DOI:10.1016/j.atherosclerosis.2016.10.044.
[22]ROQUER J,SEGURA T,SERENA J,et al. Endothelial dysfunction,vascular disease and stroke:the ARTICO study[J]. Cerebrovasc Dis,2009,27(Suppl 1):25-37. DOI: 10.1159/000200439.

更新日期/Last Update: 2018-05-11